Huperzine A to treat the symptoms of Alzheimer's Disease The Huperzine A study seeks volunteers who: have been diagnosed with mild to moderate Alzheimer's disease are age 55 or older are NOT currently taking cholinesterase inhibitors (such as Aricept, Exelon, or Reminyl) are on stable medications for 4 weeks prior to the screening visit; and have a study partner-a friend or relative who can accompany the volunteer to all clinic visits and answer questions about him or her.
To read more about this study: - Click here to read Huperzine A to treat the symptoms of Alzheimer's Disease Questions & Answers
- Click here to read Will this Chinese herb be an answer to treating Alzheimer's? Help us find out.
- Click here to read Huperzine to Treat Alzheimer's Disease-A New Multi-Center Clinical Trial Supported by the National Institute on Aging/AD Cooperative Study.
|
